Trajectories of squamous cell carcinoma antigen and outcomes of patients with advanced penile cancer after chemotherapy based on paclitaxel, ifosfamid, and cisplatin regimen.
Nan MaYi-Xiang GanYin-Yao ChaoZhen-Hua LiuXian-Da ChenKai YaoHui HanSheng-Jie GuoPublished in: Cancer medicine (2024)
PC patients' SCC-A change rate was associated with tumor response and patient survival after TIP chemotherapy. SCC-A might assist tumor monitoring after systemic therapies.
Keyphrases
- squamous cell carcinoma
- end stage renal disease
- locally advanced
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- depressive symptoms
- prognostic factors
- type diabetes
- case report
- chemotherapy induced
- metabolic syndrome
- rectal cancer
- insulin resistance
- squamous cell
- patient reported outcomes
- weight loss
- childhood cancer